It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMS’s FA Score shows that 0 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMS’s TA Score shows that 2 TA indicator(s) are bullish.
AMS (@Medical/Nursing Services) experienced а +2.22% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.05%. For the same industry, the average monthly price growth was +3.24%, and the average quarterly price growth was -5.61%.
AMS is expected to report earnings on Mar 27, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
AMS | ||
---|---|---|
OUTLOOK RATING 1..100 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 47 Fair valued | |
PROFIT vs RISK RATING 1..100 | 63 | |
SMR RATING 1..100 | 53 | |
PRICE GROWTH RATING 1..100 | 50 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMS | SDEM | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | N/A | 12 days ago84% |
Momentum ODDS (%) | 12 days ago73% | 12 days ago86% |
MACD ODDS (%) | N/A | N/A |
TrendWeek ODDS (%) | 12 days ago64% | 12 days ago81% |
TrendMonth ODDS (%) | 12 days ago66% | 12 days ago81% |
Advances ODDS (%) | 12 days ago73% | 14 days ago81% |
Declines ODDS (%) | 14 days ago63% | 12 days ago81% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 12 days ago76% | N/A |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DFVEX | 28.05 | 0.18 | +0.65% |
DFA US Vector Equity I | |||
EIVFX | 13.26 | 0.07 | +0.53% |
Allspring Special Large Cap Value R6 | |||
CMCRX | 42.74 | 0.17 | +0.40% |
Calvert US Mid Cap Core Rspnb Idx R6 | |||
ETMGX | 32.70 | 0.09 | +0.28% |
Eaton Vance Tx-Mgd Small-Cap A | |||
NUIIX | 28.41 | -0.01 | -0.04% |
Nuveen International Dividend Growth I |
A.I.dvisor tells us that SDEM and EAST have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SDEM and EAST's prices will move in lockstep.
Ticker / NAME | Correlation To SDEM | 1D Price Change % | ||
---|---|---|---|---|
SDEM | 100% | +0.86% | ||
EAST - SDEM | 9% Poorly correlated | -5.16% | ||
SOL - SDEM | 1% Poorly correlated | -1.92% | ||
LU - SDEM | 1% Poorly correlated | N/A | ||
MCB - SDEM | -1% Poorly correlated | +0.86% | ||
AMS - SDEM | -2% Poorly correlated | +3.87% | ||
More |